NEW DELHI – Two health advocacy groups have written to the Indian government asking it to rescind patents given to Gilead Sciences for the drug remdesivir so it can be distributed more fairly to coronavirus patients around the world, particularly in poorer nations. Drug patents in India are […]
TOKYO – Japan has begun treating severely ill COVID-19 patients with Gilead Sciences Inc’s COVID-19 remdesivir drug, a health ministry official said, just days after giving the drug emergency approval as it seeks to curb the coronavirus outbreak. Ministry official Yasuyuki Sahara said in an e-mail on Thursday […]
Gilead Sciences Inc said on Tuesday it has signed non-exclusive licensing pacts with five generic drugmakers based in India and Pakistan to expand the supply of its experimental COVID-19 treatment remdesivir. The pacts allow the companies – Jubilant Life Sciences Ltd, Cipla Ltd , Hetero Labs Ltd, Mylan […]
More than half of a group of severely ill coronavirus patients improved after receiving an experimental antiviral drug, although there’s no way to know the odds of that happening without the drug because there was no comparison group, doctors reported Friday. The results published by the New England Journal of […]
Founder Editor
